11.08.2011 • NewsLanxessQ2 2011Axel Heitmann

Lanxess Posts €181 Million Q2 Net Income

Lanxess posted second quarter net income of €181 million or €2.17 per share, up from €131 million or €1.57 per share last year. EBITDA pre exceptionals in the second quarter rose 26% year-over-year to €339 million.

Sales grew to €2.24 billion from €1.83 billion in the prior-year quarter. Lanxess said it implemented price increases in all segments in order to fully pass on higher raw material costs. In addition, there was volume growth and positive portfolio effects from recent acquisitions, above all the EPDM rubber business DSM Elastomers. Sales grew despite negative currency effects at minus 7% mainly due to a weak U.S. dollar.

"Demand for our products remains strong and plants are running at very high capacity utilization rates," said CEO Axel Heitmann. "Against this background and the strong first half of the year, we are lifting our full-year earnings guidance."

EBITDA pre exceptionals is now expected to grow about 20% year-on-year compared to €918 million in 2010. Earlier, EBITDA pre exceptionals were expected to grow 10-15%.

 

Company

Logo:

LANXESS Deutschland GmbH

Kennedyplatz 1
50569 Köln
Germany

Company contact







Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.